Skip to content
Medical Health Aged Care

Last Chance to Enter the QV HCP Student Scholarship, $30,000 to be won!

Ego Pharmaceuticals < 1 mins read

Closing September 30th 2023, the QV Healthcare Practitioner Student Scholarship will award a total of $30,000 in prize money to undergraduate and postgraduate students in Pharmacy, Medicine or Nursing courses in a bid to further the education of the next generation of Australian healthcare practitioners.

Entrants are asked to complete a short essay related to sensitive skin, an area QV understands well having spent decades specialising in skincare for sensitive and problematic skin. Submissions will be judged by a panel of industry experts including Fabrizio Spada (Scientific Affairs Manager, Ego Pharmaceuticals) and Cheryl Talent (President, Eczema Association of Australasia).

QV Skincare, part of the Ego Pharmaceuticals portfolio, has a long and close association with healthcare practitioners since the business was first founded following a request from the dermatology ward of Melbourne’s iconic Queen Victoria Hospital.

Decades on, the QV brand remains family owned, Australian made, and synonymous with quality and innovation. With over 50 QV products sold in more than 20 nations around the world, QV is proud to be the #1 recommended sensitive skincare brand by healthcare practitioners^, a testament to the trust dermatologists, GPs and pharmacists have in the brand.

The QV Healthcare Practitioner Student Scholarship is open from September 1st until September 30th 2023. Interested parties can enter via www.qvskincare.com.au/scholarship.html

 

^ACA Research, Sponsored by Ego Pharmaceuticals, OTC Skincare, n = 330 (Pharmacists, GPs and Dermatologists across Australia). June 2021.


Contact details:

[email protected]

+61 438 763 996

Media

More from this category

  • Community, Medical Health Aged Care
  • 08/12/2025
  • 04:15
Save Our Sons Duchenne Foundation

Global Clinical Experts Gather in Sydney to Advance Adult Duchenne Muscular Dystrophy Care

Key Facts: Life expectancy for Australians living with DMD have increased from 18 for those borne before 1970, to around 30 today. As adult care remains fragmented and inconsistent between hospitals and States, the Symposium will develop global multi-disciplinary care recommendations.MEDIA RELEASE A world-first International Symposium dedicated toimproving multi-disciplinary clinical care for adults living with Duchenne muscular dystrophy (DMD) will take place in Sydney over the next three days. Hosted by the Save Our Sons Duchenne Foundation, the invitation-only event will bring together more than 35 of the world’s leading clinicians and researchers to develop the first multidisciplinary, global best-practice…

  • Contains:
  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.